Global Long-acting G-CSF Market Growth (Status and Outlook) 2026-2032
The global Long-acting G-CSF market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Granulocyte colony stimulating factor (G-CSF) is a type of growth factor. G-CSF is a drug that’s most often prescribed after chemotherapy. It helps increase white blood cells called neutrophils that protect the patient from infection. Neutrophils are often destroyed during chemotherapy, causing a condition called neutropenia. G-CSF can also increase the number of stem cells before or after a stem cell transplant. Long-acting G-CSF has a long plasma half-life and only needs to be administered once per chemotherapy cycle.
United States market for Long-acting G-CSF is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Long-acting G-CSF is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Long-acting G-CSF is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Long-acting G-CSF players cover Amgen Inc., Pfizer, Sandoz (Novartis), Biocon Biologics Inc., Coherus BioSciences, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Long-acting G-CSF Industry Forecast” looks at past sales and reviews total world Long-acting G-CSF sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-acting G-CSF sales for 2026 through 2032. With Long-acting G-CSF sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting G-CSF industry.
This Insight Report provides a comprehensive analysis of the global Long-acting G-CSF landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long-acting G-CSF portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-acting G-CSF market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting G-CSF and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting G-CSF.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting G-CSF market by product type, application, key players and key regions and countries.
Segmentation by Type:
Granulocyte colony stimulating factor (G-CSF) is a type of growth factor. G-CSF is a drug that’s most often prescribed after chemotherapy. It helps increase white blood cells called neutrophils that protect the patient from infection. Neutrophils are often destroyed during chemotherapy, causing a condition called neutropenia. G-CSF can also increase the number of stem cells before or after a stem cell transplant. Long-acting G-CSF has a long plasma half-life and only needs to be administered once per chemotherapy cycle.
United States market for Long-acting G-CSF is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Long-acting G-CSF is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Long-acting G-CSF is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Long-acting G-CSF players cover Amgen Inc., Pfizer, Sandoz (Novartis), Biocon Biologics Inc., Coherus BioSciences, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Long-acting G-CSF Industry Forecast” looks at past sales and reviews total world Long-acting G-CSF sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-acting G-CSF sales for 2026 through 2032. With Long-acting G-CSF sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting G-CSF industry.
This Insight Report provides a comprehensive analysis of the global Long-acting G-CSF landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long-acting G-CSF portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-acting G-CSF market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting G-CSF and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting G-CSF.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting G-CSF market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Pegfilgrastim
- Filgrastim Biosimilar
- Others
- Neoplastic Diseases
- Blood Disorders
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen Inc.
- Pfizer
- Sandoz (Novartis)
- Biocon Biologics Inc.
- Coherus BioSciences, Inc.
- Spectrum Pharmaceuticals
- Yifan Pharmaceutical
- CSPC
- Jiangsu Hengrui Medicine
- Qilu Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting G-CSF Market Size (2021-2032)
2.1.2 Long-acting G-CSF Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Long-acting G-CSF by Country/Region (2021, 2025 & 2032)
2.2 Long-acting G-CSF Segment by Type
2.2.1 Pegfilgrastim
2.2.2 Filgrastim Biosimilar
2.2.3 Others
2.2.4 Long-acting G-CSF Market Size by Type
2.2.4.1 Long-acting G-CSF Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Long-acting G-CSF Market Size Market Share by Type (2021-2026)
2.3 Long-acting G-CSF Segment by Application
2.3.1 Neoplastic Diseases
2.3.2 Blood Disorders
2.3.3 Others
2.3.4 Long-acting G-CSF Market Size by Application
2.3.4.1 Long-acting G-CSF Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Long-acting G-CSF Market Size Market Share by Application (2021-2026)
3 LONG-ACTING G-CSF MARKET SIZE BY PLAYER
3.1 Long-acting G-CSF Market Size Market Share by Player
3.1.1 Global Long-acting G-CSF Revenue by Player (2021-2026)
3.1.2 Global Long-acting G-CSF Revenue Market Share by Player (2021-2026)
3.2 Global Long-acting G-CSF Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LONG-ACTING G-CSF BY REGION
4.1 Long-acting G-CSF Market Size by Region (2021-2026)
4.2 Global Long-acting G-CSF Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-acting G-CSF Market Size Growth (2021-2026)
4.4 APAC Long-acting G-CSF Market Size Growth (2021-2026)
4.5 Europe Long-acting G-CSF Market Size Growth (2021-2026)
4.6 Middle East & Africa Long-acting G-CSF Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Long-acting G-CSF Market Size by Country (2021-2026)
5.2 Americas Long-acting G-CSF Market Size by Type (2021-2026)
5.3 Americas Long-acting G-CSF Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting G-CSF Market Size by Region (2021-2026)
6.2 APAC Long-acting G-CSF Market Size by Type (2021-2026)
6.3 APAC Long-acting G-CSF Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Long-acting G-CSF Market Size by Country (2021-2026)
7.2 Europe Long-acting G-CSF Market Size by Type (2021-2026)
7.3 Europe Long-acting G-CSF Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting G-CSF by Region (2021-2026)
8.2 Middle East & Africa Long-acting G-CSF Market Size by Type (2021-2026)
8.3 Middle East & Africa Long-acting G-CSF Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LONG-ACTING G-CSF MARKET FORECAST
10.1 Global Long-acting G-CSF Forecast by Region (2027-2032)
10.1.1 Global Long-acting G-CSF Forecast by Region (2027-2032)
10.1.2 Americas Long-acting G-CSF Forecast
10.1.3 APAC Long-acting G-CSF Forecast
10.1.4 Europe Long-acting G-CSF Forecast
10.1.5 Middle East & Africa Long-acting G-CSF Forecast
10.2 Americas Long-acting G-CSF Forecast by Country (2027-2032)
10.2.1 United States Market Long-acting G-CSF Forecast
10.2.2 Canada Market Long-acting G-CSF Forecast
10.2.3 Mexico Market Long-acting G-CSF Forecast
10.2.4 Brazil Market Long-acting G-CSF Forecast
10.3 APAC Long-acting G-CSF Forecast by Region (2027-2032)
10.3.1 China Long-acting G-CSF Market Forecast
10.3.2 Japan Market Long-acting G-CSF Forecast
10.3.3 Korea Market Long-acting G-CSF Forecast
10.3.4 Southeast Asia Market Long-acting G-CSF Forecast
10.3.5 India Market Long-acting G-CSF Forecast
10.3.6 Australia Market Long-acting G-CSF Forecast
10.4 Europe Long-acting G-CSF Forecast by Country (2027-2032)
10.4.1 Germany Market Long-acting G-CSF Forecast
10.4.2 France Market Long-acting G-CSF Forecast
10.4.3 UK Market Long-acting G-CSF Forecast
10.4.4 Italy Market Long-acting G-CSF Forecast
10.4.5 Russia Market Long-acting G-CSF Forecast
10.5 Middle East & Africa Long-acting G-CSF Forecast by Region (2027-2032)
10.5.1 Egypt Market Long-acting G-CSF Forecast
10.5.2 South Africa Market Long-acting G-CSF Forecast
10.5.3 Israel Market Long-acting G-CSF Forecast
10.5.4 Turkey Market Long-acting G-CSF Forecast
10.6 Global Long-acting G-CSF Forecast by Type (2027-2032)
10.7 Global Long-acting G-CSF Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Long-acting G-CSF Forecast
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Information
11.1.2 Amgen Inc. Long-acting G-CSF Product Offered
11.1.3 Amgen Inc. Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Amgen Inc. Main Business Overview
11.1.5 Amgen Inc. Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Long-acting G-CSF Product Offered
11.2.3 Pfizer Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Information
11.3.2 Sandoz (Novartis) Long-acting G-CSF Product Offered
11.3.3 Sandoz (Novartis) Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sandoz (Novartis) Main Business Overview
11.3.5 Sandoz (Novartis) Latest Developments
11.4 Biocon Biologics Inc.
11.4.1 Biocon Biologics Inc. Company Information
11.4.2 Biocon Biologics Inc. Long-acting G-CSF Product Offered
11.4.3 Biocon Biologics Inc. Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Biocon Biologics Inc. Main Business Overview
11.4.5 Biocon Biologics Inc. Latest Developments
11.5 Coherus BioSciences, Inc.
11.5.1 Coherus BioSciences, Inc. Company Information
11.5.2 Coherus BioSciences, Inc. Long-acting G-CSF Product Offered
11.5.3 Coherus BioSciences, Inc. Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Coherus BioSciences, Inc. Main Business Overview
11.5.5 Coherus BioSciences, Inc. Latest Developments
11.6 Spectrum Pharmaceuticals
11.6.1 Spectrum Pharmaceuticals Company Information
11.6.2 Spectrum Pharmaceuticals Long-acting G-CSF Product Offered
11.6.3 Spectrum Pharmaceuticals Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Spectrum Pharmaceuticals Main Business Overview
11.6.5 Spectrum Pharmaceuticals Latest Developments
11.7 Yifan Pharmaceutical
11.7.1 Yifan Pharmaceutical Company Information
11.7.2 Yifan Pharmaceutical Long-acting G-CSF Product Offered
11.7.3 Yifan Pharmaceutical Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Yifan Pharmaceutical Main Business Overview
11.7.5 Yifan Pharmaceutical Latest Developments
11.8 CSPC
11.8.1 CSPC Company Information
11.8.2 CSPC Long-acting G-CSF Product Offered
11.8.3 CSPC Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 CSPC Main Business Overview
11.8.5 CSPC Latest Developments
11.9 Jiangsu Hengrui Medicine
11.9.1 Jiangsu Hengrui Medicine Company Information
11.9.2 Jiangsu Hengrui Medicine Long-acting G-CSF Product Offered
11.9.3 Jiangsu Hengrui Medicine Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Jiangsu Hengrui Medicine Main Business Overview
11.9.5 Jiangsu Hengrui Medicine Latest Developments
11.10 Qilu Pharmaceutical
11.10.1 Qilu Pharmaceutical Company Information
11.10.2 Qilu Pharmaceutical Long-acting G-CSF Product Offered
11.10.3 Qilu Pharmaceutical Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Qilu Pharmaceutical Main Business Overview
11.10.5 Qilu Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting G-CSF Market Size (2021-2032)
2.1.2 Long-acting G-CSF Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Long-acting G-CSF by Country/Region (2021, 2025 & 2032)
2.2 Long-acting G-CSF Segment by Type
2.2.1 Pegfilgrastim
2.2.2 Filgrastim Biosimilar
2.2.3 Others
2.2.4 Long-acting G-CSF Market Size by Type
2.2.4.1 Long-acting G-CSF Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Long-acting G-CSF Market Size Market Share by Type (2021-2026)
2.3 Long-acting G-CSF Segment by Application
2.3.1 Neoplastic Diseases
2.3.2 Blood Disorders
2.3.3 Others
2.3.4 Long-acting G-CSF Market Size by Application
2.3.4.1 Long-acting G-CSF Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Long-acting G-CSF Market Size Market Share by Application (2021-2026)
3 LONG-ACTING G-CSF MARKET SIZE BY PLAYER
3.1 Long-acting G-CSF Market Size Market Share by Player
3.1.1 Global Long-acting G-CSF Revenue by Player (2021-2026)
3.1.2 Global Long-acting G-CSF Revenue Market Share by Player (2021-2026)
3.2 Global Long-acting G-CSF Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LONG-ACTING G-CSF BY REGION
4.1 Long-acting G-CSF Market Size by Region (2021-2026)
4.2 Global Long-acting G-CSF Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-acting G-CSF Market Size Growth (2021-2026)
4.4 APAC Long-acting G-CSF Market Size Growth (2021-2026)
4.5 Europe Long-acting G-CSF Market Size Growth (2021-2026)
4.6 Middle East & Africa Long-acting G-CSF Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Long-acting G-CSF Market Size by Country (2021-2026)
5.2 Americas Long-acting G-CSF Market Size by Type (2021-2026)
5.3 Americas Long-acting G-CSF Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting G-CSF Market Size by Region (2021-2026)
6.2 APAC Long-acting G-CSF Market Size by Type (2021-2026)
6.3 APAC Long-acting G-CSF Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Long-acting G-CSF Market Size by Country (2021-2026)
7.2 Europe Long-acting G-CSF Market Size by Type (2021-2026)
7.3 Europe Long-acting G-CSF Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting G-CSF by Region (2021-2026)
8.2 Middle East & Africa Long-acting G-CSF Market Size by Type (2021-2026)
8.3 Middle East & Africa Long-acting G-CSF Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LONG-ACTING G-CSF MARKET FORECAST
10.1 Global Long-acting G-CSF Forecast by Region (2027-2032)
10.1.1 Global Long-acting G-CSF Forecast by Region (2027-2032)
10.1.2 Americas Long-acting G-CSF Forecast
10.1.3 APAC Long-acting G-CSF Forecast
10.1.4 Europe Long-acting G-CSF Forecast
10.1.5 Middle East & Africa Long-acting G-CSF Forecast
10.2 Americas Long-acting G-CSF Forecast by Country (2027-2032)
10.2.1 United States Market Long-acting G-CSF Forecast
10.2.2 Canada Market Long-acting G-CSF Forecast
10.2.3 Mexico Market Long-acting G-CSF Forecast
10.2.4 Brazil Market Long-acting G-CSF Forecast
10.3 APAC Long-acting G-CSF Forecast by Region (2027-2032)
10.3.1 China Long-acting G-CSF Market Forecast
10.3.2 Japan Market Long-acting G-CSF Forecast
10.3.3 Korea Market Long-acting G-CSF Forecast
10.3.4 Southeast Asia Market Long-acting G-CSF Forecast
10.3.5 India Market Long-acting G-CSF Forecast
10.3.6 Australia Market Long-acting G-CSF Forecast
10.4 Europe Long-acting G-CSF Forecast by Country (2027-2032)
10.4.1 Germany Market Long-acting G-CSF Forecast
10.4.2 France Market Long-acting G-CSF Forecast
10.4.3 UK Market Long-acting G-CSF Forecast
10.4.4 Italy Market Long-acting G-CSF Forecast
10.4.5 Russia Market Long-acting G-CSF Forecast
10.5 Middle East & Africa Long-acting G-CSF Forecast by Region (2027-2032)
10.5.1 Egypt Market Long-acting G-CSF Forecast
10.5.2 South Africa Market Long-acting G-CSF Forecast
10.5.3 Israel Market Long-acting G-CSF Forecast
10.5.4 Turkey Market Long-acting G-CSF Forecast
10.6 Global Long-acting G-CSF Forecast by Type (2027-2032)
10.7 Global Long-acting G-CSF Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Long-acting G-CSF Forecast
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Information
11.1.2 Amgen Inc. Long-acting G-CSF Product Offered
11.1.3 Amgen Inc. Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Amgen Inc. Main Business Overview
11.1.5 Amgen Inc. Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Long-acting G-CSF Product Offered
11.2.3 Pfizer Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Information
11.3.2 Sandoz (Novartis) Long-acting G-CSF Product Offered
11.3.3 Sandoz (Novartis) Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sandoz (Novartis) Main Business Overview
11.3.5 Sandoz (Novartis) Latest Developments
11.4 Biocon Biologics Inc.
11.4.1 Biocon Biologics Inc. Company Information
11.4.2 Biocon Biologics Inc. Long-acting G-CSF Product Offered
11.4.3 Biocon Biologics Inc. Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Biocon Biologics Inc. Main Business Overview
11.4.5 Biocon Biologics Inc. Latest Developments
11.5 Coherus BioSciences, Inc.
11.5.1 Coherus BioSciences, Inc. Company Information
11.5.2 Coherus BioSciences, Inc. Long-acting G-CSF Product Offered
11.5.3 Coherus BioSciences, Inc. Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Coherus BioSciences, Inc. Main Business Overview
11.5.5 Coherus BioSciences, Inc. Latest Developments
11.6 Spectrum Pharmaceuticals
11.6.1 Spectrum Pharmaceuticals Company Information
11.6.2 Spectrum Pharmaceuticals Long-acting G-CSF Product Offered
11.6.3 Spectrum Pharmaceuticals Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Spectrum Pharmaceuticals Main Business Overview
11.6.5 Spectrum Pharmaceuticals Latest Developments
11.7 Yifan Pharmaceutical
11.7.1 Yifan Pharmaceutical Company Information
11.7.2 Yifan Pharmaceutical Long-acting G-CSF Product Offered
11.7.3 Yifan Pharmaceutical Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Yifan Pharmaceutical Main Business Overview
11.7.5 Yifan Pharmaceutical Latest Developments
11.8 CSPC
11.8.1 CSPC Company Information
11.8.2 CSPC Long-acting G-CSF Product Offered
11.8.3 CSPC Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 CSPC Main Business Overview
11.8.5 CSPC Latest Developments
11.9 Jiangsu Hengrui Medicine
11.9.1 Jiangsu Hengrui Medicine Company Information
11.9.2 Jiangsu Hengrui Medicine Long-acting G-CSF Product Offered
11.9.3 Jiangsu Hengrui Medicine Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Jiangsu Hengrui Medicine Main Business Overview
11.9.5 Jiangsu Hengrui Medicine Latest Developments
11.10 Qilu Pharmaceutical
11.10.1 Qilu Pharmaceutical Company Information
11.10.2 Qilu Pharmaceutical Long-acting G-CSF Product Offered
11.10.3 Qilu Pharmaceutical Long-acting G-CSF Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Qilu Pharmaceutical Main Business Overview
11.10.5 Qilu Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-acting G-CSF Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Long-acting G-CSF Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Pegfilgrastim
Table 4. Major Players of Filgrastim Biosimilar
Table 5. Major Players of Others
Table 6. Long-acting G-CSF Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Long-acting G-CSF Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Long-acting G-CSF Market Size Market Share by Type (2021-2026)
Table 9. Long-acting G-CSF Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Long-acting G-CSF Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Long-acting G-CSF Market Size Market Share by Application (2021-2026)
Table 12. Global Long-acting G-CSF Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Long-acting G-CSF Revenue Market Share by Player (2021-2026)
Table 14. Long-acting G-CSF Key Players Head office and Products Offered
Table 15. Long-acting G-CSF Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Long-acting G-CSF Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Long-acting G-CSF Market Size Market Share by Region (2021-2026)
Table 20. Global Long-acting G-CSF Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Long-acting G-CSF Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Long-acting G-CSF Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Long-acting G-CSF Market Size Market Share by Country (2021-2026)
Table 24. Americas Long-acting G-CSF Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Long-acting G-CSF Market Size Market Share by Type (2021-2026)
Table 26. Americas Long-acting G-CSF Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Long-acting G-CSF Market Size Market Share by Application (2021-2026)
Table 28. APAC Long-acting G-CSF Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Long-acting G-CSF Market Size Market Share by Region (2021-2026)
Table 30. APAC Long-acting G-CSF Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Long-acting G-CSF Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Long-acting G-CSF Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Long-acting G-CSF Market Size Market Share by Country (2021-2026)
Table 34. Europe Long-acting G-CSF Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Long-acting G-CSF Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Long-acting G-CSF Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Long-acting G-CSF Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Long-acting G-CSF Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Long-acting G-CSF
Table 40. Key Market Challenges & Risks of Long-acting G-CSF
Table 41. Key Industry Trends of Long-acting G-CSF
Table 42. Global Long-acting G-CSF Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Long-acting G-CSF Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Long-acting G-CSF Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Long-acting G-CSF Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Amgen Inc. Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 47. Amgen Inc. Long-acting G-CSF Product Offered
Table 48. Amgen Inc. Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Amgen Inc. Main Business
Table 50. Amgen Inc. Latest Developments
Table 51. Pfizer Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 52. Pfizer Long-acting G-CSF Product Offered
Table 53. Pfizer Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Sandoz (Novartis) Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 57. Sandoz (Novartis) Long-acting G-CSF Product Offered
Table 58. Sandoz (Novartis) Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Sandoz (Novartis) Main Business
Table 60. Sandoz (Novartis) Latest Developments
Table 61. Biocon Biologics Inc. Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 62. Biocon Biologics Inc. Long-acting G-CSF Product Offered
Table 63. Biocon Biologics Inc. Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Biocon Biologics Inc. Main Business
Table 65. Biocon Biologics Inc. Latest Developments
Table 66. Coherus BioSciences, Inc. Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 67. Coherus BioSciences, Inc. Long-acting G-CSF Product Offered
Table 68. Coherus BioSciences, Inc. Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Coherus BioSciences, Inc. Main Business
Table 70. Coherus BioSciences, Inc. Latest Developments
Table 71. Spectrum Pharmaceuticals Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 72. Spectrum Pharmaceuticals Long-acting G-CSF Product Offered
Table 73. Spectrum Pharmaceuticals Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Spectrum Pharmaceuticals Main Business
Table 75. Spectrum Pharmaceuticals Latest Developments
Table 76. Yifan Pharmaceutical Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 77. Yifan Pharmaceutical Long-acting G-CSF Product Offered
Table 78. Yifan Pharmaceutical Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Yifan Pharmaceutical Main Business
Table 80. Yifan Pharmaceutical Latest Developments
Table 81. CSPC Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 82. CSPC Long-acting G-CSF Product Offered
Table 83. CSPC Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. CSPC Main Business
Table 85. CSPC Latest Developments
Table 86. Jiangsu Hengrui Medicine Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 87. Jiangsu Hengrui Medicine Long-acting G-CSF Product Offered
Table 88. Jiangsu Hengrui Medicine Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Jiangsu Hengrui Medicine Main Business
Table 90. Jiangsu Hengrui Medicine Latest Developments
Table 91. Qilu Pharmaceutical Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 92. Qilu Pharmaceutical Long-acting G-CSF Product Offered
Table 93. Qilu Pharmaceutical Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Qilu Pharmaceutical Main Business
Table 95. Qilu Pharmaceutical Latest Developments
Table 1. Long-acting G-CSF Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Long-acting G-CSF Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Pegfilgrastim
Table 4. Major Players of Filgrastim Biosimilar
Table 5. Major Players of Others
Table 6. Long-acting G-CSF Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Long-acting G-CSF Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Long-acting G-CSF Market Size Market Share by Type (2021-2026)
Table 9. Long-acting G-CSF Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Long-acting G-CSF Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Long-acting G-CSF Market Size Market Share by Application (2021-2026)
Table 12. Global Long-acting G-CSF Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Long-acting G-CSF Revenue Market Share by Player (2021-2026)
Table 14. Long-acting G-CSF Key Players Head office and Products Offered
Table 15. Long-acting G-CSF Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Long-acting G-CSF Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Long-acting G-CSF Market Size Market Share by Region (2021-2026)
Table 20. Global Long-acting G-CSF Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Long-acting G-CSF Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Long-acting G-CSF Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Long-acting G-CSF Market Size Market Share by Country (2021-2026)
Table 24. Americas Long-acting G-CSF Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Long-acting G-CSF Market Size Market Share by Type (2021-2026)
Table 26. Americas Long-acting G-CSF Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Long-acting G-CSF Market Size Market Share by Application (2021-2026)
Table 28. APAC Long-acting G-CSF Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Long-acting G-CSF Market Size Market Share by Region (2021-2026)
Table 30. APAC Long-acting G-CSF Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Long-acting G-CSF Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Long-acting G-CSF Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Long-acting G-CSF Market Size Market Share by Country (2021-2026)
Table 34. Europe Long-acting G-CSF Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Long-acting G-CSF Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Long-acting G-CSF Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Long-acting G-CSF Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Long-acting G-CSF Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Long-acting G-CSF
Table 40. Key Market Challenges & Risks of Long-acting G-CSF
Table 41. Key Industry Trends of Long-acting G-CSF
Table 42. Global Long-acting G-CSF Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Long-acting G-CSF Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Long-acting G-CSF Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Long-acting G-CSF Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Amgen Inc. Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 47. Amgen Inc. Long-acting G-CSF Product Offered
Table 48. Amgen Inc. Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Amgen Inc. Main Business
Table 50. Amgen Inc. Latest Developments
Table 51. Pfizer Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 52. Pfizer Long-acting G-CSF Product Offered
Table 53. Pfizer Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Sandoz (Novartis) Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 57. Sandoz (Novartis) Long-acting G-CSF Product Offered
Table 58. Sandoz (Novartis) Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Sandoz (Novartis) Main Business
Table 60. Sandoz (Novartis) Latest Developments
Table 61. Biocon Biologics Inc. Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 62. Biocon Biologics Inc. Long-acting G-CSF Product Offered
Table 63. Biocon Biologics Inc. Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Biocon Biologics Inc. Main Business
Table 65. Biocon Biologics Inc. Latest Developments
Table 66. Coherus BioSciences, Inc. Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 67. Coherus BioSciences, Inc. Long-acting G-CSF Product Offered
Table 68. Coherus BioSciences, Inc. Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Coherus BioSciences, Inc. Main Business
Table 70. Coherus BioSciences, Inc. Latest Developments
Table 71. Spectrum Pharmaceuticals Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 72. Spectrum Pharmaceuticals Long-acting G-CSF Product Offered
Table 73. Spectrum Pharmaceuticals Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Spectrum Pharmaceuticals Main Business
Table 75. Spectrum Pharmaceuticals Latest Developments
Table 76. Yifan Pharmaceutical Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 77. Yifan Pharmaceutical Long-acting G-CSF Product Offered
Table 78. Yifan Pharmaceutical Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Yifan Pharmaceutical Main Business
Table 80. Yifan Pharmaceutical Latest Developments
Table 81. CSPC Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 82. CSPC Long-acting G-CSF Product Offered
Table 83. CSPC Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. CSPC Main Business
Table 85. CSPC Latest Developments
Table 86. Jiangsu Hengrui Medicine Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 87. Jiangsu Hengrui Medicine Long-acting G-CSF Product Offered
Table 88. Jiangsu Hengrui Medicine Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Jiangsu Hengrui Medicine Main Business
Table 90. Jiangsu Hengrui Medicine Latest Developments
Table 91. Qilu Pharmaceutical Details, Company Type, Long-acting G-CSF Area Served and Its Competitors
Table 92. Qilu Pharmaceutical Long-acting G-CSF Product Offered
Table 93. Qilu Pharmaceutical Long-acting G-CSF Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Qilu Pharmaceutical Main Business
Table 95. Qilu Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Long-acting G-CSF Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Long-acting G-CSF Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Long-acting G-CSF Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Long-acting G-CSF Sales Market Share by Country/Region (2025)
Figure 8. Long-acting G-CSF Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Long-acting G-CSF Market Size Market Share by Type in 2025
Figure 10. Long-acting G-CSF in Neoplastic Diseases
Figure 11. Global Long-acting G-CSF Market: Neoplastic Diseases (2021-2026) & ($ millions)
Figure 12. Long-acting G-CSF in Blood Disorders
Figure 13. Global Long-acting G-CSF Market: Blood Disorders (2021-2026) & ($ millions)
Figure 14. Long-acting G-CSF in Others
Figure 15. Global Long-acting G-CSF Market: Others (2021-2026) & ($ millions)
Figure 16. Global Long-acting G-CSF Market Size Market Share by Application in 2025
Figure 17. Global Long-acting G-CSF Revenue Market Share by Player in 2025
Figure 18. Global Long-acting G-CSF Market Size Market Share by Region (2021-2026)
Figure 19. Americas Long-acting G-CSF Market Size 2021-2026 ($ millions)
Figure 20. APAC Long-acting G-CSF Market Size 2021-2026 ($ millions)
Figure 21. Europe Long-acting G-CSF Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Long-acting G-CSF Market Size 2021-2026 ($ millions)
Figure 23. Americas Long-acting G-CSF Value Market Share by Country in 2025
Figure 24. United States Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Long-acting G-CSF Market Size Market Share by Region in 2025
Figure 29. APAC Long-acting G-CSF Market Size Market Share by Type (2021-2026)
Figure 30. APAC Long-acting G-CSF Market Size Market Share by Application (2021-2026)
Figure 31. China Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 35. India Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Long-acting G-CSF Market Size Market Share by Country in 2025
Figure 38. Europe Long-acting G-CSF Market Size Market Share by Type (2021-2026)
Figure 39. Europe Long-acting G-CSF Market Size Market Share by Application (2021-2026)
Figure 40. Germany Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 41. France Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Long-acting G-CSF Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Long-acting G-CSF Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Long-acting G-CSF Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 54. APAC Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 55. Europe Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 57. United States Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 58. Canada Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 59. Mexico Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 60. Brazil Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 61. China Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 62. Japan Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 63. Korea Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 65. India Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 66. Australia Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 67. Germany Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 68. France Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 69. UK Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 70. Italy Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 71. Russia Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 72. Egypt Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 73. South Africa Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 74. Israel Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 75. Turkey Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 76. Global Long-acting G-CSF Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Long-acting G-CSF Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 1. Long-acting G-CSF Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Long-acting G-CSF Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Long-acting G-CSF Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Long-acting G-CSF Sales Market Share by Country/Region (2025)
Figure 8. Long-acting G-CSF Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Long-acting G-CSF Market Size Market Share by Type in 2025
Figure 10. Long-acting G-CSF in Neoplastic Diseases
Figure 11. Global Long-acting G-CSF Market: Neoplastic Diseases (2021-2026) & ($ millions)
Figure 12. Long-acting G-CSF in Blood Disorders
Figure 13. Global Long-acting G-CSF Market: Blood Disorders (2021-2026) & ($ millions)
Figure 14. Long-acting G-CSF in Others
Figure 15. Global Long-acting G-CSF Market: Others (2021-2026) & ($ millions)
Figure 16. Global Long-acting G-CSF Market Size Market Share by Application in 2025
Figure 17. Global Long-acting G-CSF Revenue Market Share by Player in 2025
Figure 18. Global Long-acting G-CSF Market Size Market Share by Region (2021-2026)
Figure 19. Americas Long-acting G-CSF Market Size 2021-2026 ($ millions)
Figure 20. APAC Long-acting G-CSF Market Size 2021-2026 ($ millions)
Figure 21. Europe Long-acting G-CSF Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Long-acting G-CSF Market Size 2021-2026 ($ millions)
Figure 23. Americas Long-acting G-CSF Value Market Share by Country in 2025
Figure 24. United States Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Long-acting G-CSF Market Size Market Share by Region in 2025
Figure 29. APAC Long-acting G-CSF Market Size Market Share by Type (2021-2026)
Figure 30. APAC Long-acting G-CSF Market Size Market Share by Application (2021-2026)
Figure 31. China Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 35. India Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Long-acting G-CSF Market Size Market Share by Country in 2025
Figure 38. Europe Long-acting G-CSF Market Size Market Share by Type (2021-2026)
Figure 39. Europe Long-acting G-CSF Market Size Market Share by Application (2021-2026)
Figure 40. Germany Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 41. France Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Long-acting G-CSF Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Long-acting G-CSF Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Long-acting G-CSF Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Long-acting G-CSF Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 54. APAC Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 55. Europe Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 57. United States Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 58. Canada Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 59. Mexico Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 60. Brazil Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 61. China Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 62. Japan Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 63. Korea Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 65. India Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 66. Australia Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 67. Germany Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 68. France Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 69. UK Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 70. Italy Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 71. Russia Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 72. Egypt Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 73. South Africa Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 74. Israel Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 75. Turkey Long-acting G-CSF Market Size 2027-2032 ($ millions)
Figure 76. Global Long-acting G-CSF Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Long-acting G-CSF Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Long-acting G-CSF Market Size 2027-2032 ($ millions)
